Image

European Newborn Study: Early Markers for a Better LifE

European Newborn Study: Early Markers for a Better LifE

Recruiting
2 years and younger
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to create a computer model to help doctors predict any problems occurring during development of babies after being diagnosed with brain injury. This will help provide better care to future babies. Next to this, the experiences of parents or caregivers surrounding the first two years after birth of a baby at risk of developing cerebral palsy will be researched to develop recommendations to support parents.

Parents of participants will:

  • Fill in two online questionnaires, one when their child is 3-4 months corrected age. The second when their child is 2 years corrected age.

For the child no additional tests are needed. Only tests that are part of standard clinical practice are performed and are also saved in the study database.

Eligibility

Inclusion Criteria:

  • All infants with confirmed brain injury on MRI at high risk for CP.

Particularly, infants with the following brain injuries at risk for CP will be considered on MRI at term equivalent age or within 10 days after birth or sentinel event:

  • Extensive punctate white matter injury.
  • Periventricular hemorrhagic infarction (any location).
  • Cerebellar injury (ischemic and/or hemorrhages) involving the vermis or involving more than 1/3 of the cerebellar hemisphere and/or lesions involving the cerebellar vermis (Meijler & Steggerda, 2019).
  • Cystic periventricular leukomalacia (grade 3 & 4).
  • intraventricular hemorrhages grade III.
  • Posthemorrhagic ventricular dilatation exceeding the 97°percentile + 4mm for the ventricular index (Cizmeci et al., 2020).
  • Perinatal asphyxia with hypoxic ischemic injury of the central gray matter and/or perirolandic area.
  • Perinatal asphyxia with hypoxic ischemic injury in the watershed areas.
  • Perinatal ischemic arterial stroke at high risk for CP, thus with involvement of the corticospinal tracts, cortex, white matter and basal ganglia (Wagenaar et al., 2018).
  • Presence of other brain injuries with expected adverse motor outcome (i.e. big subdural and parenchymal bleedings with/without midline shift, bilirubin induced brain injury) in preterm infants, term infants with neonatal encephalopathy with/without neonatal seizures.
    • Written informed parental consent (Dutch, English, French, German, Italian, Spanish).

Exclusion Criteria:

  • Infants not matching the inclusion criteria.
  • Any proven or suspected severe congenital anomaly, genetic or metabolic disorder.
  • Presence of an infection of the central nervous system.
  • Parents < 18 years old.
  • Not being able to read one of the six Informed Consent languages.

Study details
    Cerebral Palsy

NCT07189494

dr. M.J.N.L. Benders

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.